Infinity Pharmaceuticals, Inc. Payments for Restructuring
Infinity Pharmaceuticals, Inc. reported Payments for Restructuring of $842.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2023-08-10
- Infinity Pharmaceuticals, Inc. payments for restructuring for the quarter ending 2023-06-30 was $784.00K.
- Infinity Pharmaceuticals, Inc. payments for restructuring for the quarter ending 2023-03-31 was $58.00K.
- Infinity Pharmaceuticals, Inc. payments for restructuring for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Infinity Pharmaceuticals, Inc. payments for restructuring for the quarter ending 2017-09-30 was $689.00K, a 87.59% decline year-over-year.
- Infinity Pharmaceuticals, Inc. payments for restructuring for fiscal 2017 was $6.67M, a 35.47% decline from fiscal 2016.
- Infinity Pharmaceuticals, Inc. payments for restructuring for fiscal 2016 was $10.34M.
- Infinity Pharmaceuticals, Inc. payments for restructuring for fiscal 2012 was $2.19M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2023-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $842.00K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $58.00K 10-Q · filed 2023-05-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $689.00K derived: sum of 2 quarters · filed 2018-03-15 | $1.47M derived: sum of 3 quarters · filed 2018-03-15 | $6.67M 10-K · filed 2018-03-15 |
| 2017-09-30 | $689.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.47M derived: sum of 2 quarters · filed 2017-11-07 | $6.67M 10-Q · filed 2017-11-07 | $11.36M derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-06-30 | $785.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $5.98M 10-Q · filed 2017-08-03 | $10.67M derived: sum of 3 quarters · filed 2017-08-03 | $16.22M derived: sum of 4 quarters · filed 2017-08-03 |
| 2017-03-31 | $5.20M 10-Q · filed 2017-05-09 | $9.88M derived: sum of 2 quarters · filed 2017-05-09 | $15.44M derived: sum of 3 quarters · filed 2017-05-09 | |
| 2016-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $10.24M derived: sum of 2 quarters · filed 2017-03-14 | $10.34M 10-K · filed 2017-03-14 | |
| 2016-09-30 | $5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $5.65M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $97.00K 10-Q · filed 2016-08-09 | |||
| 2013-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $377.00K 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | $279.00K 10-Q · filed 2013-05-07 | |||
| 2012-12-31 | $2.19M 10-K · filed 2013-03-05 |